MacroGenics Inc (MGNX) stock
MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.20−0.09 (-3.93%)
Close on Nov 13, 2026Market cap $140.14MP/E –Yield –
MacroGenics operating margin
Operating margin is operating income as a percentage of revenue.
MacroGenics's operating margin for the twelve months ending Sep 30, 2026 was -41.5%. For fiscal 2025 it was -48.7%, against -73.7% the year before. The highest annual figure on record is 12.9% in fiscal 2012.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -48.7% | +25.0 |
| FY2024 | Dec 31, 2024 | -73.7% | +212.6 |
| FY2023 | Dec 31, 2023 | -286.4% | −206.5 |
| FY2022 | Dec 31, 2022 | -79.9% | +181.9 |
| FY2021 | Dec 31, 2021 | -261.9% | −136.9 |
| FY2020 | Dec 31, 2020 | -125.0% | +151.1 |
| FY2019 | Dec 31, 2019 | -276.0% | +8.7 |
| FY2018 | Dec 31, 2018 | -284.8% | −270.7 |
| FY2017 | Dec 31, 2017 | -14.0% | +51.3 |
| FY2016 | Dec 31, 2016 | -65.3% | −45.3 |
| FY2015 | Dec 31, 2015 | -20.0% | +60.2 |
| FY2014 | Dec 31, 2014 | -80.2% | −80.8 |
| FY2013 | Dec 31, 2013 | 0.6% | −12.2 |
| FY2012 | Dec 31, 2012 | 12.9% | +3.7 |
| FY2011 | Dec 31, 2011 | 9.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -108.8% | −128.4 |
| Q2 FY2026 | Jun 30, 2026 | -42.2% | +587.1 |
| Q1 FY2026 | Mar 31, 2026 | -161.0% | +162.1 |
| Q4 FY2025 | Dec 31, 2025 | 4.1% | +277.1 |
| Q3 FY2025 | Sep 30, 2025 | 19.6% | −29.3 |
| Q2 FY2025 | Jun 30, 2025 | -629.3% | −90.4 |
| Q1 FY2025 | Mar 31, 2025 | -323.1% | +267.3 |
| Q4 FY2024 | Dec 31, 2024 | -273.0% | +187.4 |
| Q3 FY2024 | Sep 30, 2024 | 48.9% | +390.4 |
| Q2 FY2024 | Jun 30, 2024 | -538.9% | −196.6 |
| Q1 FY2024 | Mar 31, 2024 | -590.4% | −433.5 |
| Q4 FY2023 | Dec 31, 2023 | -460.4% | −476.8 |
| Q3 FY2023 | Sep 30, 2023 | -341.5% | −281.7 |
| Q2 FY2023 | Jun 30, 2023 | -342.3% | −181.5 |
| Q1 FY2023 | Mar 31, 2023 | -156.9% | +443.4 |
| Q4 FY2022 | Dec 31, 2022 | 16.4% | +428.0 |
| Q3 FY2022 | Sep 30, 2022 | -59.8% | +278.5 |
| Q2 FY2022 | Jun 30, 2022 | -160.8% | −29.8 |
| Q1 FY2022 | Mar 31, 2022 | -600.3% | −296.4 |
| Q4 FY2021 | Dec 31, 2021 | -411.6% | −407.5 |
| Q3 FY2021 | Sep 30, 2021 | -338.3% | −140.3 |
| Q2 FY2021 | Jun 30, 2021 | -131.0% | +102.6 |
| Q1 FY2021 | Mar 31, 2021 | -303.9% | +28.3 |
| Q4 FY2020 | Dec 31, 2020 | -4.1% | +149.3 |
| Q3 FY2020 | Sep 30, 2020 | -198.0% | +4.5 |
| Q2 FY2020 | Jun 30, 2020 | -233.5% | +266.5 |
| Q1 FY2020 | Mar 31, 2020 | -332.2% | +160.7 |
| Q4 FY2019 | Dec 31, 2019 | -153.4% | +110.4 |
| Q3 FY2019 | Sep 30, 2019 | -202.5% | −34.2 |
| Q2 FY2019 | Jun 30, 2019 | -500.0% | −264.8 |
| Q1 FY2019 | Mar 31, 2019 | -492.8% | +576.6 |
| Q4 FY2018 | Dec 31, 2018 | -263.9% | −332.8 |
| Q3 FY2018 | Sep 30, 2018 | -168.3% | +2701.4 |
| Q2 FY2018 | Jun 30, 2018 | -235.3% | +2236.4 |
| Q1 FY2018 | Mar 31, 2018 | -1069.4% | +789.8 |
| Q4 FY2017 | Dec 31, 2017 | 68.9% | +759.0 |
| Q3 FY2017 | Sep 30, 2017 | -2869.8% | – |
| Q2 FY2017 | Jun 30, 2017 | -2471.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -1859.3% | – |
| Q4 FY2016 | Dec 31, 2016 | -690.1% | – |
See a number that looks wrong?